COURTNEY CAHILL: Open Payments
NPI 1346453487 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 39 payments from 13 companies in 2025. Trend: 2023 $731 · 2024 $943 · 2025 $759
Food & beverage: $687Education: $72
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $171 |
| Regeneron Healthcare Solutions, Inc. | 4 | $114 |
| MAYNE PHARMA COMMERCIAL LLC | 11 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $72 |
| PFIZER INC. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| Galderma Laboratories, L.P. | 2 | $52 |
| UCB, Inc. | 3 | $48 |
| Arcutis Biotherapeutics, Inc. | 1 | $26 |
| LEO Pharma Inc. | 1 | $24 |
Products named: DUPIXENT, CIBINQO, COSENTYX, NEMLUVIO, Bimzelx, Zoryve, LIBTAYO, ADBRY.
Industry payments across AZ — which companies pay providers there.
